OR WAIT null SECS
June 22, 2018
The agency published guidance about requests for Prescription Drug User Fee Act waivers, refunds, and reductions in user fees.
The approval is intended to increase patient access to treatment for opioid addiction.
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
FDA, EMA, and senior officials from the European Commission met to discuss the EU-US mutual recognition agreement for inspections, the development of advanced therapies, the requirements for approving generic drugs, and Real-World Evidence used for post-authorization monitoring.
June 21, 2018
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
June 20, 2018
The company has resubmitted a biologics license application to FDA for its proposed biosimilar to Roche’s Herceptin.
June 19, 2018
The extension provides four additional process development laboratories at its Nottingham site to improve output and efficiency in drug development and clinical trial manufacturing operations.
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
June 18, 2018
Intelligent manufacturing and environmental policies are key trends at P-MEC 2018.
June 14, 2018
Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.